Linda Greub

Linda Greub, CFA, MBA, currently serves as a Board Member at Clarified Precision Medicine and a Managing Partner at Avestria Ventures, focusing on investments in early-stage women's health and life science ventures. With a wealth of experience, Linda has held several board positions, including member of the Board of Directors at Mae and Board Observer roles at Raydiant Oximetry, Inc. and AmplifiDx. Previously, Linda was the CEO of Muir Partners, specializing in life science consulting and financial advisory, and has held leadership roles in corporate development at RainDance Technologies and Singulex. Linda's career also includes directing diagnostics strategy at Novartis. An accomplished academic, Linda holds an MBA from Harvard Business School and a BA in History of Art from Yale University, along with ongoing education in leadership, strategy, mergers and acquisitions, and negotiation from esteemed institutions.